Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|September 28, 2005
The NF-kappaB signalling pathway: a therapeutic target in lymphoid malignancies?Archontoula StoffelBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 24, 2010
Targeted therapies for solid tumors: current status and future perspectivesArchontoula StoffelCell Cycle (Georgetown, Tex.)|July 29, 2004
Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53Archontoula Stoffel, Arnold J LevineLeukemia Research|October 12, 2004
The p73 locus is commonly deleted in non-Hodgkin's lymphomasArchontoula Stoffel, Daniel Filippa, Pulivarthi H RaoProceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesisArchontoula Stoffel, Mira Chaurushiya, Bhuvanesh Singh, et al.Genes & Development|February 6, 2003
CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammalsShengkan Jin, Markus Kalkum, Michael Overholtzer, et al.The American Journal of Pathology|August 7, 2002
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh, Archontoula Stoffel, Swarna Gogineni, et al.Genes & Development|April 18, 2002
p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomasBhuvanesh Singh, Pabbathi G Reddy, Andy Goberdhan, et al.Cancer Research|October 5, 2006
Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomasInderpal Sarkaria, Pornchai O-charoenrat, Simon G Talbot, et al.Pageof 1